Thorsten Lubinski
CEO

DiaMonTech is developing a non-invasive blood glucose monitoring device that utilizes patented mid-infrared laser technology to detect glucose molecules in interstitial fluid without the need for test strips or invasive procedures. This device aims to provide accurate and painless glucose measurements within seconds, significantly improving diabetes management for users.
Raised to date
$14MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.



CEO
Current methods for blood glucose monitoring rely on invasive procedures, such as finger pricks, or require the use of test strips, causing discomfort and inconvenience for individuals managing diabetes. These methods can also be costly and may not provide real-time, continuous glucose readings.
DiaMonTech is developing the d-pocket, a non-invasive blood glucose monitoring device that utilizes mid-infrared laser technology to detect glucose molecules in the interstitial fluid. The device aims to provide accurate and painless glucose measurements within seconds, without the need for test strips or invasive procedures. By scanning the tissue fluid in the skin with short infrared light pulses, the device detects glucose molecules, offering a convenient and less intrusive method for diabetes management. The d-pocket is designed to be user-friendly, with a measurement process similar to unlocking a mobile phone with a fingerprint sensor.
The primary target audience includes individuals with diabetes seeking a less invasive and more convenient method for blood glucose monitoring, as well as healthcare providers looking for innovative solutions for diabetes management.